MCM
CLB icon

McKinley Capital Management’s Core Laboratories CLB Stock Holding History

McKinley Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,190
Closed -$253K – 479
2017
Q1 		$253K Buy
+2,190
New +$255K 0.01% 331
2014
Q2 		– Sell
-3,126
Closed -$620K – 352
2014
Q1 		$620K Sell
3,126
-4,699
-60% -$887K 0.03% 256
2013
Q4 		$1.49M Buy
7,825
+5,681
+265% +$1.06M 0.06% 212
2013
Q3 		$363K Buy
+2,144
New +$333K 0.02% 315

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

McKinley Capital Management's CLB Position: Q2 2017 in Review

McKinley Capital Management sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 2,190 shares — an estimated $253K sold.

McKinley Capital Management first reported a position in CLB in Q3 2013 and held it in 4 quarters. The position peaked at $1.49M in Q4 2013. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • McKinley Capital Management reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
  • McKinley Capital Management sold 2,190 Core Laboratories shares in Q2 2017, an estimated $253K.
  • McKinley Capital Management first reported a position in Core Laboratories in Q3 2013 and held it in 4 quarters.
  • McKinley Capital Management's Core Laboratories position peaked at $1.49M in Q4 2013.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on McKinley Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.